Estudio multicéntrico, aleatorizado, abierto y de grupos paralelos para comparar el inicio del tratamiento con LCZ696 antes y después del alta hospitalaria en pacientes con insuficiencia cardíaca con fracción de eyección reducida hospitalizados por un episodio de descompensación aguda (ADHF)

LCZ696

LCZ696 film-coated tables were supplied to the investigators. Tablets were taken with a glass of water, and were administered with or without food. The target dose of LCZ696 was 200 mg twice daily. Starting dose of LCZ696 was either 50 or 100 mg, twice daily. The dose of LCZ696 should be doubled every 2-4 weeks to achieve the target dose of 200 mg twice daily, as tolerated by the patient.